Literature DB >> 25860817

Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome.

Meghan S Soustek1, Celine Baligand, Darin J Falk, Glenn A Walter, Alfred S Lewin, Barry J Byrne.   

Abstract

Barth syndrome (BTHS) is an X-linked metabolic disorder that causes cardiomyopathy in infancy and is linked to mutations within the Tafazzin (TAZ) gene. The first mouse model, a TAZ knockdown model (TAZKD), has been generated to further understand the bioenergetics leading to cardiomyopathy. However, the TAZKD model does not show early signs of cardiomyopathy, and cardiac pathophysiology has not been documented until 7-8 months of age. Here we sought to determine the impact of endurance training on the cardiac and skeletal muscle phenotype in young TAZKD mice. TAZKD exercise trained (TAZKD-ET) and control exercise trained (CON-ET) mice underwent a 35-day swimming protocol. Non-trained aged matched TAZKD and CON mice were used as controls. At the end of the protocol, cardiac MRI was used to assess cardiac parameters. Cardiac MRI showed that training resulted in cardiac hypertrophy within both groups and did not result in a decline of ejection fraction. TAZKD mice exhibited a decrease in respiratory complex I, III, and IV enzymatic activity in cardiac tissue compared to control mice; however, training led to an increase in complex III activity in TAZKD-ET mice resulting in similar levels to those of CON-ET mice. (31)P magnetic resonance spectroscopy of the gastrocnemius showed a significantly lowered pH in TAZKD-ET mice post electrical-stimulation compared to CON-ET mice. Endurance training does not accelerate cardiac dysfunction in young TAZKD mice, but results in beneficial physiological effects. Furthermore, our results suggest that a significant drop in intracellular pH levels may contribute to oxidative phosphorylation defects during exercise.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25860817     DOI: 10.1007/s10545-015-9834-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  29 in total

1.  C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Authors:  Pontus Boström; Nina Mann; Jun Wu; Pablo A Quintero; Eva R Plovie; Daniela Panáková; Rana K Gupta; Chunyang Xiao; Calum A MacRae; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy.

Authors:  Tina D Jeppesen; Marianne Schwartz; David B Olsen; Flemming Wibrand; Thomas Krag; Morten Dunø; Simon Hauerslev; John Vissing
Journal:  Brain       Date:  2006-06-30       Impact factor: 13.501

3.  Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.

Authors:  Meghan S Soustek; Darin J Falk; Cathryn S Mah; Matthew J Toth; Michael Schlame; Alfred S Lewin; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

Review 4.  Reactive oxygen species and mitochondrial diseases.

Authors:  I G Kirkinezos; C T Moraes
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

5.  Impaired cardiac reserve and severely diminished skeletal muscle O₂ utilization mediate exercise intolerance in Barth syndrome.

Authors:  Carolyn T Spencer; Barry J Byrne; Randall M Bryant; Renee Margossian; Melissa Maisenbacher; Petar Breitenger; Paul B Benni; Sharon Redfearn; Edward Marcus; W Todd Cade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-26       Impact factor: 4.733

6.  Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.

Authors:  Devrim Acehan; Frederic Vaz; Riekelt H Houtkooper; Jeanne James; Vicky Moore; Chonan Tokunaga; Willem Kulik; Janaka Wansapura; Matthew J Toth; Arnold Strauss; Zaza Khuchua
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

7.  Cardiac and clinical phenotype in Barth syndrome.

Authors:  Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

8.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts.

Authors:  P G Barth; C Van den Bogert; P A Bolhuis; H R Scholte; A H van Gennip; R B Schutgens; A G Ketel
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

9.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells.

Authors:  Marco Spinazzi; Alberto Casarin; Vanessa Pertegato; Leonardo Salviati; Corrado Angelini
Journal:  Nat Protoc       Date:  2012-05-31       Impact factor: 13.491

10.  Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.

Authors:  Colin K L Phoon; Devrim Acehan; Michael Schlame; David L Stokes; Irit Edelman-Novemsky; Dawen Yu; Yang Xu; Nitya Viswanathan; Mindong Ren
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  8 in total

Review 1.  Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Authors:  Hana M Zegallai; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2021-01-07       Impact factor: 3.396

Review 2.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

Review 3.  Barth Syndrome Cardiomyopathy: An Update.

Authors:  Jing Pang; Yutong Bao; Kalia Mitchell-Silbaugh; Jennifer Veevers; Xi Fang
Journal:  Genes (Basel)       Date:  2022-04-08       Impact factor: 4.141

4.  AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome.

Authors:  Silveli Suzuki-Hatano; Madhurima Saha; Skylar A Rizzo; Rachael L Witko; Bennett J Gosiker; Manashwi Ramanathan; Meghan S Soustek; Michael D Jones; Peter B Kang; Barry J Byrne; W Todd Cade; Christina A Pacak
Journal:  Hum Gene Ther       Date:  2018-10-03       Impact factor: 5.695

Review 5.  Looking Beyond Structure: Membrane Phospholipids of Skeletal Muscle Mitochondria.

Authors:  Timothy D Heden; P Darrell Neufer; Katsuhiko Funai
Journal:  Trends Endocrinol Metab       Date:  2016-06-28       Impact factor: 12.015

Review 6.  A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?

Authors:  Mindong Ren; Paighton C Miller; Michael Schlame; Colin K L Phoon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

Review 7.  Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach.

Authors:  Stacey Reynolds
Journal:  J Multidiscip Healthc       Date:  2015-07-29

8.  Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H2 O2 production in heart and skeletal muscle mitochondria.

Authors:  Renata L S Goncalves; Michael Schlame; Alexander Bartelt; Martin D Brand; Gökhan S Hotamışlıgil
Journal:  FEBS Lett       Date:  2020-11-19       Impact factor: 4.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.